CD56+monocytes and CD31+endothelial cells as blood markers of COVID-19 disease severity

被引:0
|
作者
Dutt, Taru S. [1 ]
Lavergne, Stephanie M. [2 ]
Webb, Tracy L. [3 ]
Baxter, Bridget A. [2 ]
Stromberg, Sophia [4 ]
Berry, Kailey [5 ]
Tipton, Madison [6 ]
Dunn, Julie [7 ]
Tamayo, Marcela Henao [1 ]
Ryan, Elizabeth P. [2 ]
机构
[1] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA
[2] Colorado State Univ, Dept Environm Radiol & Hlth Sci, Ft Collins, CO 80523 USA
[3] Colorado State Univ, Dept Clin Sci, Ft Collins, CO 80523 USA
[4] Colorado State Univ, Dept Food Sci & Human Nutr, Ft Collins, CO 80523 USA
[5] Dept Mol Cellular & Integrat Neurosci, Ft Collins, CO USA
[6] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA
[7] Univ Colorado Hlth, Med Ctr Rockies, Loveland, CO USA
关键词
Biomarkers; infectious disease; memory; viral infections; visualizing immune responses;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P-1155
引用
收藏
页码:384 / 384
页数:1
相关论文
共 50 条
  • [41] Role of CD39 in COVID-19 Severity: Dysregulation of Purinergic Signaling and Thromboinflammation
    Diaz-Garcia, Elena
    Garcia-Tovar, Sara
    Alfaro, Enrique
    Zamarron, Ester
    Mangas, Alberto
    Galera, Raul
    Ruiz-Hernandez, Jose Juan
    Sole-Violan, Jordi
    Rodriguez-Gallego, Carlos
    Van-Den-Rym, Ana
    Perez-de-Diego, Rebeca
    Nanwani-Nanwani, Kapil
    Lopez-Collazo, Eduardo
    Garcia-Rio, Francisco
    Cubillos-Zapata, Carolina
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [42] Role of CD39 in COVID-19 severity: dysregulation of purinergic signaling and thromboinflammation
    Diaz-Garcia, Elena
    Garcia-Tovar, Sara
    Alfaro Garcia, Enrique
    Zamarron, Ester
    Mangas, Alberto
    Galera, Raul
    Juan Ruiz-Hernandez, Jose
    Sole-Violan, Jordi
    Rodriguez-Gallego, Carlos
    Van-Den-Rym, Ana
    Perez-De-Diego, Rebeca
    Nanwani-Nanwani, Kapil
    Lopez-Collazo, Eduardo
    Garcia-Rio, Francisco
    Cubillos-Zapata, Carolina
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [43] Role of CD39 in COVID-19 Severity: Dysregulation of Purinergic Signaling and Thromboinflammation
    Alfaro, E.
    Diaz-Garcia, E.
    Garcia-Tovar, S.
    Zamarron, E.
    Mangas, A.
    Galera, R.
    Ruiz-Hernandez, J.
    Sole-Violan, J.
    Rodriguez-Gallego, C.
    Van-Den-Rym, A.
    Perez-De-Diego, R.
    Nanwani-Nanwani, K.
    Lopez-Collazo, E.
    Garcia-Rio, F.
    Cubillos, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [44] Prediction of atherosclerosis in severe COVID-19 patients with CD16 and CD18 markers and inflammatory factors
    Mardani, R.
    Shahali, M.
    CLINICA CHIMICA ACTA, 2024, 558 : 11 - 11
  • [45] Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis
    Chen, Ding
    Ireland, Sara J.
    Davis, Laurie S.
    Kong, Xiangmei
    Stowe, Ann M.
    Wang, Yue
    White, Wendy I.
    Herbst, Ronald
    Monson, Nancy L.
    JOURNAL OF IMMUNOLOGY, 2016, 196 (04): : 1541 - 1549
  • [46] LOW CD4+COUNT CORRELATION WITH INFLAMMATORY MARKERS IN ACUTE COVID-19
    Ramirez, Claudia
    Ziad, Mohamed
    Bhalla, Sushen
    Lopez, Jesus Salvador Gonzalez
    Cruz, Ailine Canete
    Almaguer, Angelica
    Emeaba, Ndiya
    Akinwale, David
    Hussaini, Najia N.
    Varon, Daryelle S.
    Gathe, Joseph C.
    Surani, Salim R.
    Varon, Joseph
    CHEST, 2022, 162 (04) : 859A - 860A
  • [47] Expansion of peripheral blood CD81/CD5+B cells and its relation to disease severity and autoimmune markers in chronic HCV infection
    Zuckerman, E
    Slobodin, G
    Kessel, A
    Sabo, E
    Yeshurun, D
    Toubi, E
    JOURNAL OF HEPATOLOGY, 2001, 34 : 126 - 126
  • [48] The frequencies of peripheral blood CD5+CD19+ B cells, CD3-CD16+CD56+ NK, and CD3+CD56+ NKT cells and serum interleukin-10 in patients with multiple sclerosis and neuromyelitis optica spectrum disorder
    Khani, Leila
    Jazayeri, Mir Hadi
    Nedaeinia, Reza
    Bozorgmehr, Mahmood
    Nabavi, Seyed Masood
    Ferns, Gordon A.
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2022, 18 (01):
  • [49] mRNA levels of CD31, CD144, CD146 and von Willebrand factor do not serve as surrogate markers for circulating endothelial cells
    Strijbos, Michiel H.
    van Krimpen, Brigitte A.
    Debets, Reno
    Kraan, Jaco
    Sleijfer, Stefan
    Gratama, Jan Willem
    Lamers, Cor H. J.
    THROMBOSIS AND HAEMOSTASIS, 2010, 104 (02) : 318 - 326
  • [50] Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity
    Sindelar, Miriam
    Stancliffe, Ethan
    Schwaiger-Haber, Michaela
    Anbukumar, Dhanalakshmi S.
    Adkins-Travis, Kayla
    Goss, Charles W.
    O'Halloran, Jane A.
    Mudd, Philip A.
    Liu, Wen-Chun
    Albrecht, Randy A.
    Garcia-Sastre, Adolfo
    Shriver, Leah P.
    Patti, Gary J.
    CELL REPORTS MEDICINE, 2021, 2 (08)